Income Statement Abpro Bio Co., Ltd.

Equities

A195990

KR7195990007

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 2026-01-15			5-day change	1st Jan Change
189.00 ^KRW	-3.57%		-12.09%	-27.31%

25-10-01	Investors left reading tea leaves
25-08-25	Abpro Bio Co., Ltd.(KOSDAQ:A195990) dropped from S&P Global BMI Index	CI

187.wpSW9-YGVUa9XvPugP1ss7oad_bJnUeY6jhDP-rZ6QQ.uOz-mLVBYijzGJHe7bA63vdROaWlsB7qq0sMZbW3vHyk3afBoFwxAI9ngA

Published financial data: ABPRO BIO CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	49.28B	32.91B	22.11B	25.38B	31.66B
Other Revenues, Total	-	-	-10	-	-
Total Revenues	49.28B	32.91B	22.11B	25.38B	31.66B
Cost of Goods Sold, Total	43.79B	28.99B	20.49B	24.11B	31.05B
Gross Profit	5.49B	3.93B	1.62B	1.27B	616M
Selling General & Admin Expenses, Total	6.82B	7.85B	8.54B	8.27B	9.25B
Provision for Bad Debts	3.29B	-65.3M	2.57B	1.56B	-3.75B
R&D Expenses	1.29B	562M	880M	573M	448M
Depreciation & Amortization - (IS)	702M	422M	563M	710M	691M
Amortization of Goodwill and Intangible Assets - (IS)	1.02B	60.63M	1.47M	5.24M	73.65M
Other Operating Expenses	415M	433M	252M	324M	445M
Other Operating Expenses, Total	13.54B	9.26B	12.81B	11.44B	7.16B
Operating Income	-8.04B	-5.33B	-11.19B	-10.18B	-6.54B
Interest Expense, Total	-5.04B	-6.86B	-4.59B	-2.34B	-2.09B
Interest And Investment Income	535M	576M	168M	302M	654M
Net Interest Expenses	-4.5B	-6.28B	-4.42B	-2.04B	-1.44B
Income (Loss) On Equity Invest.	-8.77B	-5.88B	4.22B	-9.38B	-27.88B
Currency Exchange Gains (Loss)	-1.18B	2.39B	1.76B	521M	7.2B
Other Non Operating Income (Expenses)	-20.01B	8.61B	-867M	-1.01B	2.99B
EBT, Excl. Unusual Items	-42.51B	-6.49B	-10.51B	-22.09B	-25.67B
Gain (Loss) On Sale Of Investments	-4.43B	-	2.52B	16.29M	579K
Gain (Loss) On Sale Of Assets	9.07M	650M	329M	-2.56B	11.8B
Asset Writedown	-12.25B	-3.83B	-487M	-1.03B	-2.19B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-59.18B	-9.68B	-8.14B	-25.66B	-16.06B
Income Tax Expense	2.44B	64.59M	-	84.12M	-426M
Earnings From Continuing Operations	-61.62B	-9.74B	-8.14B	-25.74B	-15.63B
Earnings Of Discontinued Operations	-	-775M	-	-	-
Net Income to Company	-61.62B	-10.52B	-8.14B	-25.74B	-15.63B
Minority Interest	2.65B	485M	-	-	-
Net Income - (IS)	-58.97B	-10.03B	-8.14B	-25.74B	-15.63B
Net Income to Common Incl Extra Items	-58.97B	-10.03B	-8.14B	-25.74B	-15.63B
Net Income to Common Excl. Extra Items	-58.97B	-9.26B	-8.14B	-25.74B	-15.63B
Per Share Items
Net EPS - Basic	-276.73	-39.85	-30.36	-92.51	-54.9
Basic EPS - Continuing Operations	-276.73	-36.77	-30.36	-92.51	-54.9
Basic Weighted Average Shares Outstanding	213M	252M	268M	278M	285M
Net EPS - Diluted	-292.08	-43.31	-30.36	-92.51	-57.27
Diluted EPS - Continuing Operations	-292.08	-40.43	-30.36	-92.51	-57.27
Diluted Weighted Average Shares Outstanding	214M	270M	268M	278M	292M
Normalized Basic EPS	-112.27	-14.19	-24.47	-49.6	-56.35
Normalized Diluted EPS	-111.65	-13.25	-24.47	-49.6	-55.02
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	-795M	-2.71B	-9.79B	-8.31B	-5.06B
EBITA	-7.01B	-5.27B	-11.19B	-10.14B	-6.44B
EBIT	-8.04B	-5.33B	-11.19B	-10.18B	-6.54B
Effective Tax Rate - (Ratio)	-4.12	-0.67	-	-0.33	2.65
Normalized Net Income	-23.92B	-3.57B	-6.57B	-13.8B	-16.04B
Supplemental Operating Expense Items
Advertising Expense	-	-	297M	1.92M	2.3M
Selling and Marketing Expenses	1.67B	3.07B	3.54B	3.15B	3.11B
General and Administrative Expenses	278M	87.92M	91.04M	96.15M	168M
Research And Development Expense From Footnotes	1.29B	562M	880M	573M	448M
Stock-Based Comp., SG&A Exp. (Total)	335M	261M	-	-	-
Total Stock-Based Compensation	335M	261M	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	26.84B	53.96B	16.95B	18.86B	15.49B
Short Term Investments	-	430M	796M	944M	6.12B
Trading Asset Securities, Total	4.04B	-	4.09B	68.36M	43.43M
Total Cash And Short Term Investments	30.89B	54.39B	21.83B	19.87B	21.66B
Accounts Receivable, Total	4.08B	2.78B	3.23B	3.99B	10.1B
Other Receivables	626M	1.41B	325M	1.04B	880M
Notes Receivable	126M	-	900M	2.83B	1.28B
Total Receivables	4.84B	4.19B	4.45B	7.87B	12.26B
Inventory	12.66B	15.19B	18.61B	16.43B	13.53B
Prepaid Expenses	564M	520M	40.62M	37.42M	598M
Other Current Assets, Total	8.86B	7.61B	857M	598M	930M
Total Current Assets	57.81B	81.9B	45.79B	44.8B	48.98B
Gross Property Plant And Equipment	57.44B	37.54B	37.31B	37.63B	29.87B
Accumulated Depreciation	-17.89B	-13.37B	-14.21B	-15.06B	-8.3B
Net Property Plant And Equipment	39.55B	24.17B	23.1B	22.58B	21.57B
Long-term Investments	61.66B	57.31B	79.77B	56.41B	43.49B
Goodwill	-	-	-	8B	13.5B
Other Intangibles, Total	500M	3.62B	2.39B	3.48B	3.34B
Accounts Receivable Long-Term	-	-	-	252M	113M
Loans Receivable Long-Term	256M	32.6M	31.32M	-	360M
Deferred Tax Assets Long-Term	-	-	-	126M	576M
Other Long-Term Assets, Total	6.26B	849M	5.56B	6.45B	9.33B
Total Assets	166B	168B	157B	142B	141B
Liabilities
Accounts Payable, Total	2.23B	2.91B	1.56B	2.13B	6.86B
Accrued Expenses, Total	1.68B	479M	734M	755M	653M
Short-term Borrowings	2.49B	21.01B	10.2B	9.25B	8.73B
Current Portion of Long-Term Debt	-	-	-	333M	971M
Current Portion of Leases	196M	214M	303M	367M	384M
Current Income Taxes Payable	3.21M	-	-	7.35M	-
Other Current Liabilities	8.23B	5.14B	3.22B	5.09B	3.42B
Total Current Liabilities	14.83B	29.76B	16.01B	17.92B	21.02B
Long-Term Debt	8.46B	-	-	1.29B	11.51B
Long-Term Leases	241M	583M	441M	551M	456M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	-	-	213M
Other Non Current Liabilities	4.29B	-	10	-440	59.75M
Total Liabilities	27.83B	30.34B	16.45B	19.77B	33.25B
Common Stock, Total	126B	130B	137B	142B	142B
Additional Paid In Capital	83.6B	85.64B	87.29B	89.12B	89.79B
Retained Earnings	-68.92B	-79.07B	-87.19B	-113B	-129B
Treasury Stock	-2.9M	-2.9M	-2.9M	-2.9M	-2.9M
Comprehensive Income and Other	-1.31B	877M	3.26B	3.82B	4.45B
Total Common Equity	139B	138B	140B	122B	108B
Minority Interest	-902M	-	-	-	-
Total Equity	138B	138B	140B	122B	108B
Total Liabilities And Equity	166B	168B	157B	142B	141B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	251M	260M	274M	285M	285M
ECS Total Common Shares Outstanding	251M	260M	274M	285M	285M
Book Value / Share	553.15	528.59	512.25	429.74	379.4
Tangible Book Value	139B	134B	138B	111B	91.18B
Tangible Book Value Per Share	551.17	514.68	503.52	389.39	320.27
Total Debt	11.39B	21.81B	10.94B	11.79B	22.05B
Net Debt	-19.49B	-32.58B	-10.89B	-8.07B	396M
Minority Interest, Total (Incl. Fin. Div)	-902M	-	-	-	-
Equity Method Investments, Total	49.61B	52.45B	68.58B	56.21B	43.44B
Inventories - Raw Materials, Total	11.41B	13.67B	16.76B	15.62B	9.82B
Inventories - Work In Process, Total	94.43M	500M	260M	1.4B	511M
Inventories - Finished Goods, Total	7.55B	7.61B	8.18B	7.32B	7.57B
Inventories - Others	-30	-300	370	240	-660
Land - (BS)	11.48B	10B	10B	10B	11.74B
Buildings, Total	26.57B	18.61B	18.49B	18.48B	9.87B
Machinery, Total	17.6B	7.22B	7.35B	7B	5.5B
Accumulated Allowance for Doubtful Accounts (Supple)	5.61B	3.47B	3.45B	3.43B	4.02B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-58.97B	-10.03B	-8.14B	-25.74B	-15.63B
Depreciation & Amortization - CF	6.22B	2.56B	1.4B	1.84B	1.38B
Amortization of Goodwill and Intangible Assets - (CF)	1.03B	62.2M	1.47M	33.18M	99.09M
Depreciation & Amortization, Total	7.25B	2.62B	1.4B	1.87B	1.48B
(Gain) Loss From Sale Of Asset	-218M	-2.3B	-142M	79.93M	-11.8B
(Gain) Loss on Sale of Investments - (CF)	975M	3.95B	-2.22B	3.24B	-7.36M
Asset Writedown & Restructuring Costs	11.49B	749M	-	254M	2.19B
(Income) Loss On Equity Investments - (CF)	13.19B	7.16B	-4.22B	9.38B	27.88B
Stock-Based Compensation (CF)	335M	261M	-	-	-
Provision and Write-off of Bad Debts	1.4B	-1.21B	-17.77M	195M	-3.78B
Other Operating Activities, Total	20.73B	-3.97B	6.39B	3.75B	-9.33B
Change In Accounts Receivable	-1.33B	2.52B	-488M	133M	1.68B
Change In Inventories	10.9B	1.46B	-3.55B	4.68B	4.46B
Change In Accounts Payable	660M	568M	-1.35B	-997M	-1.19B
Change in Unearned Revenues	-2.3B	-	-	-	-
Change In Income Taxes	-	5K	-	-	-
Change in Other Net Operating Assets	-1.35B	-4B	-119M	-1.7B	-1.71B
Cash from Operations	2.76B	-2.22B	-12.46B	-4.86B	-5.75B
Capital Expenditure	-271M	-542M	-132M	-1.15B	-17.11B
Sale of Property, Plant, and Equipment	637M	53.1M	5.18M	60.11M	28.93B
Cash Acquisitions	-356M	-	-	-7.16B	-9.99B
Divestitures	-	1.61B	-	-	-
Sale (Purchase) of Intangible assets	-383M	-3.24B	1.35B	-1.09B	1.19B
Investment in Marketable and Equity Securities, Total	150M	-161M	-14.01B	16.42B	-8.2B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-203M	5.79B	-898M	-1.58B	-4.06B
Other Investing Activities, Total	19.23M	4.85B	-7.66B	134M	2.44B
Cash from Investing	-406M	8.35B	-21.35B	5.63B	-6.79B
Short Term Debt Issued, Total	2.6B	-	-	-	5.59B
Long-Term Debt Issued, Total	10B	14.62B	-	6.9B	17.24B
Total Debt Issued	12.6B	14.62B	-	6.9B	22.83B
Short Term Debt Repaid, Total	-3.1B	-56.83M	-	-150M	-5.68B
Long-Term Debt Repaid, Total	-390M	-236M	-3.37B	-5.57B	-8.58B
Total Debt Repaid	-3.49B	-293M	-3.37B	-5.72B	-14.26B
Issuance of Common Stock	-	5.98B	-	-	-
Repurchase of Common Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	221M	-	-	-20	-10
Cash from Financing	9.33B	20.3B	-3.37B	1.18B	8.57B
Foreign Exchange Rate Adjustments	476M	689M	177M	-44.09M	604M
Miscellaneous Cash Flow Adjustments	-282M	-	-	-	-
Net Change in Cash	11.88B	27.12B	-37.01B	1.9B	-3.36B
Supplemental Items
Cash Interest Paid	742M	401M	398M	417M	628M
Cash Income Tax Paid (Refund)	24.94M	130M	-34.96M	139M	-48.4K
Levered Free Cash Flow	13.23B	-12.72B	-6.72B	-6.7B	-19.27B
Unlevered Free Cash Flow	16.37B	-8.43B	-3.85B	-5.24B	-17.96B
Change In Net Working Capital	-14.47B	4.2B	-530M	-1.49B	-562M
Net Debt Issued / Repaid	9.11B	14.32B	-3.37B	1.18B	8.57B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-2.73	-2	-4.31	-4.26	-2.89
Return on Total Capital	-3.24	-2.16	-4.51	-4.46	-3.1
Return On Equity %	-47.88	-7.06	-5.86	-19.61	-13.57
Return on Common Equity	-45.97	-6.69	-5.86	-19.61	-13.57
Margin Analysis
Gross Profit Margin %	11.15	11.93	7.32	5	1.95
SG&A Margin	13.83	23.84	38.64	32.59	29.2
EBITDA Margin %	-1.61	-8.23	-44.28	-32.73	-15.98
EBITA Margin %	-14.23	-16.01	-50.61	-39.97	-20.35
EBIT Margin %	-16.32	-16.2	-50.62	-40.1	-20.66
Income From Continuing Operations Margin %	-125.03	-29.59	-36.83	-101.44	-49.36
Net Income Margin %	-119.66	-30.47	-36.83	-101.44	-49.36
Net Avail. For Common Margin %	-119.66	-28.12	-36.83	-101.44	-49.36
Normalized Net Income Margin	-48.55	-10.85	-29.69	-54.4	-50.67
Levered Free Cash Flow Margin	26.84	-38.64	-30.38	-26.41	-60.85
Unlevered Free Cash Flow Margin	33.23	-25.62	-17.41	-20.65	-56.72
Asset Turnover
Asset Turnover	0.27	0.2	0.14	0.17	0.22
Fixed Assets Turnover	1.1	1.03	0.94	1.11	1.43
Receivables Turnover (Average Receivables)	11.95	9.59	7.36	7.03	4.49
Inventory Turnover (Average Inventory)	2.96	2.08	1.21	1.38	2.07
Short Term Liquidity
Current Ratio	3.9	2.75	2.86	2.5	2.33
Quick Ratio	2.4	1.97	1.59	1.39	1.55
Operating Cash Flow to Current Liabilities	0.19	-0.07	-0.78	-0.27	-0.27
Days Sales Outstanding (Average Receivables)	30.63	38.07	49.58	51.92	81.43
Days Outstanding Inventory (Average Inventory)	123.49	175.36	301	265.29	176.63
Average Days Payable Outstanding	16.52	29.76	34.11	30.68	58.39
Cash Conversion Cycle (Average Days)	137.6	183.68	316.47	286.53	199.67
Long Term Solvency
Total Debt/Equity	8.25	15.86	7.8	9.64	20.42
Total Debt / Total Capital	7.62	13.69	7.24	8.79	16.96
LT Debt/Equity	6.3	0.42	0.31	1.51	11.08
Long-Term Debt / Total Capital	5.82	0.37	0.29	1.38	9.2
Total Liabilities / Total Assets	16.76	18.07	10.5	13.91	23.54
EBIT / Interest Expense	-1.6	-0.78	-2.44	-4.35	-3.13
EBITDA / Interest Expense	-0.16	-0.39	-2.13	-3.55	-2.42
(EBITDA - Capex) / Interest Expense	-0.21	-0.47	-2.16	-4.04	-10.61
Total Debt / EBITDA	-14.34	-8.05	-1.12	-1.42	-4.36
Net Debt / EBITDA	24.53	12.03	1.11	0.97	-0.08
Total Debt / (EBITDA - Capex)	-10.7	-6.71	-1.1	-1.25	-0.99
Net Debt / (EBITDA - Capex)	18.29	10.02	1.1	0.85	-0.02
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	54.34	-8.05	-32.82	14.76	24.78
Gross Profit, 1 Yr. Growth %	-143.32	-29.88	-58.77	-21.66	-51.42
EBITDA, 1 Yr. Growth %	-96.91	-150.56	261.55	-15.18	-39.09
EBITA, 1 Yr. Growth %	-75.04	512.98	112.34	-9.38	-36.46
EBIT, 1 Yr. Growth %	-73.32	181.99	109.89	-9.09	-35.7
Earnings From Cont. Operations, 1 Yr. Growth %	78.61	-78.24	-16.38	216.06	-39.28
Net Income, 1 Yr. Growth %	55.73	-82.99	-18.8	216.06	-39.28
Normalized Net Income, 1 Yr. Growth %	15.11	-84.14	83.81	110.23	16.22
Diluted EPS Before Extra, 1 Yr. Growth %	15.48	-82.09	-24.91	204.71	-38.09
Accounts Receivable, 1 Yr. Growth %	-1.91	-31.91	15.98	23.82	152.78
Inventory, 1 Yr. Growth %	-25.01	19.94	22.52	-11.7	-17.64
Net Property, Plant and Equip., 1 Yr. Growth %	-20.48	-38.89	-4.43	-2.25	-4.45
Total Assets, 1 Yr. Growth %	-18.16	1.12	-6.69	-9.28	-0.6
Tangible Book Value, 1 Yr. Growth %	31.59	-3.38	2.9	-19.56	-17.75
Common Equity, 1 Yr. Growth %	18.44	-1.12	1.93	-12.74	-11.71
Cash From Operations, 1 Yr. Growth %	3.29	-180.41	461.31	-60.98	18.29
Capital Expenditures, 1 Yr. Growth %	-90.28	100.24	-75.61	768.43	1.39K
Levered Free Cash Flow, 1 Yr. Growth %	-211.32	-174.26	-47.18	-0.24	187.45
Unlevered Free Cash Flow, 1 Yr. Growth %	-408.15	-141.71	-54.35	36.12	242.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-8.5	1.53	-21.41	-12.2	19.66
Gross Profit, 2 Yr. CAGR %	-21.27	-44.34	-46.23	-43.17	-38.31
EBITDA, 2 Yr. CAGR %	-34.58	-67.53	35.2	75.12	-28.12
EBITA, 2 Yr. CAGR %	81.84	-56.68	260.77	38.72	-24.12
EBIT, 2 Yr. CAGR %	39.32	-57.94	143.28	38.13	-23.54
Earnings From Cont. Operations, 2 Yr. CAGR %	149.38	-46.87	-57.34	62.57	38.53
Net Income, 2 Yr. CAGR %	130.94	-48.53	-62.84	60.2	38.53
Normalized Net Income, 2 Yr. CAGR %	140.89	-58.54	-46	96.58	56.32
Diluted EPS Before Extra, 2 Yr. CAGR %	57.3	-60.02	-63.33	51.27	37.35
Accounts Receivable, 2 Yr. CAGR %	-40.72	-18.28	-11.14	19.83	76.92
Inventory, 2 Yr. CAGR %	-29.09	-5.16	21.23	4.01	-14.72
Net Property, Plant and Equip., 2 Yr. CAGR %	-13.82	-30.29	-23.58	-3.35	-3.36
Total Assets, 2 Yr. CAGR %	-3	-9.03	-2.87	-8	-5.04
Tangible Book Value, 2 Yr. CAGR %	27.83	12.76	-0.29	-9.02	-18.66
Common Equity, 2 Yr. CAGR %	14.08	8.22	0.39	-5.69	-12.23
Cash From Operations, 2 Yr. CAGR %	5.81	-8.86	112.45	47.99	-32.06
Capital Expenditures, 2 Yr. CAGR %	-54.44	-55.89	-30.12	45.53	1.04K
Levered Free Cash Flow, 2 Yr. CAGR %	328.88	3.46	-37.37	-27.41	69.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	248.08	25.97	-56.37	-21.17	116.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.37	-17.61	-11.53	-10.84	-1.28
Gross Profit, 3 Yr. CAGR %	39.37	-23.75	-49.64	-39.05	-46.06
EBITDA, 3 Yr. CAGR %	-55.77	13.41	-27.49	15.74	23.16
EBITA, 3 Yr. CAGR %	-17.32	35.46	-26.42	127.63	6.93
EBIT, 3 Yr. CAGR %	-13.71	8.77	-28.13	75.23	7.05
Earnings From Cont. Operations, 3 Yr. CAGR %	74.84	-0.57	-38.19	-16.84	17.08
Net Income, 3 Yr. CAGR %	71.82	-3.2	-40.09	-24.14	15.93
Normalized Net Income, 3 Yr. CAGR %	32.51	-4.67	-31.89	-15.05	64.99
Diluted EPS Before Extra, 3 Yr. CAGR %	22.81	-30.03	-50.67	-25.72	12.31
Accounts Receivable, 3 Yr. CAGR %	-37.78	-37.92	-8.16	-0.75	53.69
Inventory, 3 Yr. CAGR %	-22.36	-15.51	3.29	9.07	-3.77
Net Property, Plant and Equip., 3 Yr. CAGR %	-12.55	-23.15	-22.56	-17.04	-3.72
Total Assets, 3 Yr. CAGR %	-1.16	-1.65	-8.26	-5.05	-5.59
Tangible Book Value, 3 Yr. CAGR %	16.08	16.45	9.37	-7.18	-12.03
Common Equity, 3 Yr. CAGR %	12.52	8.77	6.08	-4.19	-7.74
Cash From Operations, 3 Yr. CAGR %	-56.79	-3.44	67.06	20.76	37.35
Capital Expenditures, 3 Yr. CAGR %	-52.55	-25.37	-63.79	61.87	215.99
Levered Free Cash Flow, 3 Yr. CAGR %	3.15	160.55	-17.31	-26.85	14.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	17.09	84.1	-10.19	-36.24	28.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-8.56	-7.85	-13.61	-15.49	-0.17
Gross Profit, 5 Yr. CAGR %	-24.47	-22.23	-4.41	-32.21	-45.38
EBITDA, 5 Yr. CAGR %	-43.84	-0.85	1.29	34.94	-27.74
EBITA, 5 Yr. CAGR %	-11.31	36.25	-2.03	36.75	-25.51
EBIT, 5 Yr. CAGR %	-8.74	38.42	-2.21	19.68	-26.33
Earnings From Cont. Operations, 5 Yr. CAGR %	32.62	124.4	-6.71	21.04	-14.64
Net Income, 5 Yr. CAGR %	31.46	256.85	-6.87	18.41	-16.22
Normalized Net Income, 5 Yr. CAGR %	23.01	32.57	-8.58	27.34	-5.05
Diluted EPS Before Extra, 5 Yr. CAGR %	5.42	178.81	-28.07	-4.76	-25.7
Accounts Receivable, 5 Yr. CAGR %	-22.51	-28.88	-28.25	-19.24	19.38
Inventory, 5 Yr. CAGR %	-12.33	-10.69	-7.21	-8.19	-4.33
Net Property, Plant and Equip., 5 Yr. CAGR %	4.73	-4.8	-17.14	-15.77	-15.38
Total Assets, 5 Yr. CAGR %	3.91	0.18	-1.84	-4.24	-6.98
Tangible Book Value, 5 Yr. CAGR %	6.04	4.2	9.24	5.5	-2.84
Common Equity, 5 Yr. CAGR %	6.02	4.64	7.5	2.74	-1.66
Cash From Operations, 5 Yr. CAGR %	53.44	-26.71	-18.29	14.54	16.57
Capital Expenditures, 5 Yr. CAGR %	-34.27	-19.98	-44.6	-2.52	43.76
Levered Free Cash Flow, 5 Yr. CAGR %	16.83	45.22	-11.03	56.28	10.15
Unlevered Free Cash Flow, 5 Yr. CAGR %	23.6	44.22	-17.71	31.13	27.58